More than 60 published articles have reported on the safety, effectiveness, biomechanics and economic benefits of the iFuse Implant. Available since 2009, iFuse is the only SI joint fusion device with published results from randomized controlled trials and the only one with multiple prospective clinical studies that show iFuse improved pain, patient function, and quality of life.


Prospective (Level II)

LOIS 4-year Results (Darr - MDER 2018)

Brief Report: 4-Year Outcomes after Minimally Invasive Trans-Iliac Sacroiliac Joint Fusion with Triangular Titanium Implants.

VIEW DATA
Prospective (Level II)

LOIS 3-year Results (Darr - MDER 2018)

Long-term Prospective Outcomes After Minimally Invasive Trans-iliac Sacroiliac Joint Fusion Using Triangular Titanium Implants

VIEW DATA
Prospective (Level II)

SIFI 2-year Results (Duhon - IJSS 2016)

Triangular Titanium Implants for Minimally Invasive Sacroiliac Joint Fusion: 2-Year Follow-Up from a Prospective Multicenter Trial

VIEW DATA
Prospective (Level II)

PPGP subanalysis of SIFI (Capobianco - SpringerPlus 2015)

Safety and Effectiveness of Minimally Invasive Sacroiliac Joint Fusion in Women with Persistent Post‑partum Posterior Pelvic Girdle Pain: 12‑month Outcomes from A Prospective, Multi‑center Trial

VIEW DATA
Prospective (Level II)

SIFI 1-year Results (Duhon - Global Spine J 2015)

Triangular Titanium Implants for Minimally Invasive Sacroiliac Joint Fusion: A Prospective Study

VIEW DATA
Prospective (Level II)

Health state utility post MIS SIJ fusion (Cher - Global Spine J 2015)

Improvement in Health State Utility after Sacroiliac Joint Fusion: Comparison to Normal Populations

VIEW DATA
Prospective (Level II)

SIFI 6-month Interim Results (Duhon - MDER 2013)

Safety and 6-month Effectiveness of Minimally Invasive Sacroiliac Joint Fusion: A Prospective Study

VIEW DATA

Looking for Answers?

We can help. Tell us what you're looking for below.